4.6 Article

Low expression of INMT is associated with poor prognosis but favorable immunotherapy response in lung adenocarcinoma

Related references

Note: Only part of the references are listed.
Article Cell Biology

Indolethylamine-N-Methyltransferase Inhibits Proliferation and Promotes Apoptosis of Human Prostate Cancer Cells: A Mechanistic Exploration

Jianfeng Wang et al.

Summary: The study revealed that INMT is downregulated in prostate cancer and significantly correlated with lymph node metastasis, Gleason score, PSA expression, and survival. INMT is involved in regulating multiple signaling pathways and affects tumor microenvironments and immune cell proportions, influencing the development and drug sensitivity of prostate cancer.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

Article Oncology

Targeting INMT and interrupting its methylation pathway for the treatment of castration resistant prostate cancer

Shangwei Zhong et al.

Summary: The study identified that INMT drives PCa castration resistance through detoxification of anticancer metabolites, and targeting INMT or its regulator SMYD3 or its methylation metabolites may be an effective therapeutic approach for treating CRPC.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

Article Immunology

IOBR: Multi-Omics Immuno-Oncology Biological Research to Decode Tumor Microenvironment and Signatures

Dongqiang Zeng et al.

Summary: Recent advances in next-generation sequencing technologies have led to a rapid accumulation of publicly available multi-omics datasets. The development of IOBR as a computational tool aims to comprehensively interpret multi-omics data and facilitate immuno-oncology exploration for precision immunotherapy.

FRONTIERS IN IMMUNOLOGY (2021)

Article Oncology

Cancer statistics, 2020

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2020)

Review Immunology

Targeting the Complement Pathway as a Therapeutic Strategy in Lung Cancer

Emily K. Kleczko et al.

FRONTIERS IN IMMUNOLOGY (2019)

Article Genetics & Heredity

Tumor mutational load predicts survival after immunotherapy across multiple cancer types

Robert M. Samstein et al.

NATURE GENETICS (2019)

Article Biochemical Research Methods

GSCALite: a web server for gene set cancer analysis

Chun-Jie Liu et al.

BIOINFORMATICS (2018)

Article Multidisciplinary Sciences

TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells

Sanjeev Mariathasan et al.

NATURE (2018)

Article Medicine, Research & Experimental

IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade

Mark Ayers et al.

JOURNAL OF CLINICAL INVESTIGATION (2017)

Article Oncology

Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers

Aaron M. Goodman et al.

MOLECULAR CANCER THERAPEUTICS (2017)

Review Oncology

Monitoring immune-checkpoint blockade: response evaluation and biomarker development

Mizuki Nishino et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2017)

Article Genetics & Heredity

Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden

Zachary R. Chalmers et al.

GENOME MEDICINE (2017)

Article Oncology

Landscape of Microsatellite Instability Across 39 Cancer Types

Russell Bonneville et al.

JCO PRECISION ONCOLOGY (2017)

Article Biochemistry & Molecular Biology

Correlating chemical sensitivity and basal gene expression reveals mechanism of action

Matthew G. Rees et al.

NATURE CHEMICAL BIOLOGY (2016)

Review Oncology

Predictive Markers for the Efficacy of Anti-PD-1/PD-L1 Antibodies in Lung Cancer

Takehito Shukuya et al.

JOURNAL OF THORACIC ONCOLOGY (2016)

Article Multidisciplinary Sciences

Microarray Expression Data Identify DCC as a Candidate Gene for Early Meningioma Progression

Hans-Juergen Schulten et al.

PLOS ONE (2016)

Article Biochemistry & Molecular Biology

Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity

Michael S. Rooney et al.

Article Medicine, General & Internal

PD-1 Blockade in Tumors with Mismatch-Repair Deficiency

D. T. Le et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Article Multidisciplinary Sciences

Immunogenicity of somatic mutations in human gastrointestinal cancers

Eric Tran et al.

SCIENCE (2015)

Review Multidisciplinary Sciences

Somatic mutation in cancer and normal cells

Inigo Martincorena et al.

SCIENCE (2015)

Article Multidisciplinary Sciences

Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer

Naiyer A. Rizvi et al.

SCIENCE (2015)

Article Biochemistry & Molecular Biology

STRING v10: protein-protein interaction networks, integrated over the tree of life

Damian Szklarczyk et al.

NUCLEIC ACIDS RESEARCH (2015)

Article Multidisciplinary Sciences

Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens

Matthew M. Gubin et al.

NATURE (2014)

Article Medicine, General & Internal

Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma

Alexandra Snyder et al.

NEW ENGLAND JOURNAL OF MEDICINE (2014)

Review Immunology

Oncology Meets Immunology: The Cancer-Immunity Cycle

Daniel S. Chen et al.

IMMUNITY (2013)

Article Oncology

Identification of markers of prostate cancer progression using candidate gene expression

S. E. T. Larkin et al.

BRITISH JOURNAL OF CANCER (2012)

Article Multidisciplinary Sciences

Systematic identification of genomic markers of drug sensitivity in cancer cells

Mathew J. Garnett et al.

NATURE (2012)

Article Medicine, General & Internal

Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer

Julie R. Brahmer et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Review Biochemistry & Molecular Biology

Hallmarks of Cancer: The Next Generation

Douglas Hanahan et al.

Article Multidisciplinary Sciences

Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles

A Subramanian et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)